HomeCompareBPSR vs VICI

BPSR vs VICI: Dividend Comparison 2026

BPSR yields 3333.33% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BPSR wins by $1244041712889.41M in total portfolio value
10 years
BPSR
BPSR
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1244041712890.40M
Annual income
$1,174,716,366,071,938,000.00
Full BPSR calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — BPSR vs VICI

📍 BPSR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPSRVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPSR + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BPSR pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPSR
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$998,508,911,161,147,300.00/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, BPSR beats the other by $998,508,911,160,617,500.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPSR + VICI for your $10,000?

BPSR: 50%VICI: 50%
100% VICI50/50100% BPSR
Portfolio after 10yr
$622020856445.69M
Annual income
$587,358,183,036,280,700.00/yr
Blended yield
94.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

BPSR
No analyst data
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPSR buys
0
VICI buys
0
No recent congressional trades found for BPSR or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPSRVICI
Forward yield3333.33%6.57%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$1244041712890.40M$988.8K
Annual income after 10y$1,174,716,366,071,938,000.00$623,261.32
Total dividends collected$1239274250481.68M$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BPSR vs VICI ($10,000, DRIP)

YearBPSR PortfolioBPSR Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$344,033$333,333.33$11,368$948.43+$332.7KBPSR
2$11,085,665$10,717,549.33$13,339$1,493.16+$11.07MBPSR
3$334,616,633$322,754,971.08$16,326$2,426.21+$334.60MBPSR
4$9,462,934,690$9,104,894,892.71$21,123$4,112.15+$9462.91MBPSR
5$250,766,259,005$240,640,918,887.41$29,379$7,368.23+$250766.23MBPSR
6$6,228,082,462,189$5,959,762,565,053.11$44,804$14,191.64+$6228082.42MBPSR
7$144,998,525,500,125$138,334,477,265,582.72$76,658$29,972.12+$144998525.42MBPSR
8$3,165,074,899,913,431$3,009,926,477,628,297.00$150,894$71,015.81+$3165074899.76MBPSR
9$64,790,043,755,570,470$61,403,413,612,663,110.00$350,814$193,582.47+$64790043755.22MBPSR
10$1,244,041,712,890,398,500$1,174,716,366,071,938,000.00$988,809$623,261.32+$1244041712889.41MBPSR

BPSR vs VICI: Complete Analysis 2026

BPSRStock

Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.

Full BPSR Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this BPSR vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPSR vs SCHDBPSR vs JEPIBPSR vs OBPSR vs KOBPSR vs MAINBPSR vs NNNBPSR vs EPRTBPSR vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.